Vanguard Discloses 6.7% Passive Stake in Boston Scientific

Ticker: BSX · Form: SC 13G/A · Filed: 2024-02-13T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, passive-investing, amendment, medical-devices

TL;DR

**Vanguard still owns 6.7% of Boston Scientific, showing continued passive confidence.**

AI Summary

The Vanguard Group, a major investment firm, filed an amendment (SC 13G/A) on February 13, 2024, disclosing its ownership in Boston Scientific Corp. As of December 29, 2023, Vanguard beneficially owned 99,499,349 shares of Boston Scientific's Common Stock, representing 6.7% of the company. This filing indicates Vanguard's continued significant, but passive, stake in Boston Scientific, which is important for investors as it shows a large institutional holder maintains confidence in the company without seeking to influence management.

Why It Matters

This filing confirms that a major institutional investor, Vanguard, holds a substantial portion of Boston Scientific, signaling long-term confidence without active management intervention. For investors, this means a significant player believes in the company's value, but isn't pushing for strategic changes.

Risk Assessment

Risk Level: low — This filing is routine for large institutional investors and indicates a stable, passive ownership stake, posing minimal risk.

Analyst Insight

Investors should note Vanguard's continued significant, passive stake as a sign of institutional confidence, but understand it doesn't imply any upcoming strategic changes or activist pressure from Vanguard.

Key Numbers

99,499,349 — Shares Beneficially Owned (The total number of Boston Scientific Common Stock shares owned by The Vanguard Group as of December 29, 2023.)
6.7% — Percentage of Class (The percentage of Boston Scientific's Common Stock owned by The Vanguard Group, indicating a significant but non-controlling stake.)

Key Players & Entities

The Vanguard Group (company) — reporting person and beneficial owner
Boston Scientific Corp (company) — subject company whose securities are being reported
99,499,349 shares (dollar_amount) — number of shares beneficially owned by Vanguard
6.7% (dollar_amount) — percentage of Boston Scientific's class of securities owned by Vanguard
December 29, 2023 (date) — date of the event requiring the filing
February 13, 2024 (date) — filing date of the SC 13G/A

Forward-Looking Statements

Vanguard will maintain a significant, passive ownership stake in Boston Scientific Corp. (The Vanguard Group) — high confidence, target: Next 12-24 months

FAQ

What type of filing is this and who filed it?

This is an SC 13G/A filing, which is an amendment to a Schedule 13G. It was filed by The Vanguard Group, a major investment management company.

What company's stock is being reported in this filing?

The filing reports on the Common Stock of Boston Scientific Corp, identified by CUSIP Number 101137107.

How many shares of Boston Scientific does Vanguard beneficially own, and what percentage does that represent?

As of December 29, 2023, The Vanguard Group beneficially owned 99,499,349 shares of Boston Scientific Corp Common Stock, which represents 6.7% of the class of securities.

What was the 'Date of Event Which Requires Filing of this Statement'?

The date of the event which required the filing of this statement was December 29, 2023.

Under which rule was this Schedule 13G filed?

This Schedule 13G was filed under Rule 13d-1(b), which typically applies to institutional investors who acquire beneficial ownership of more than 5% of a class of a company's equity securities in the ordinary course of business and without the purpose or effect of changing or influencing control of the issuer.

From the Filing

0001104659-24-020459.txt : 20240213 0001104659-24-020459.hdr.sgml : 20240213 20240213170046 ACCESSION NUMBER: 0001104659-24-020459 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43484 FILM NUMBER: 24627613 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VANGUARD GROUP INC CENTRAL INDEX KEY: 0000102909 ORGANIZATION NAME: IRS NUMBER: 231945930 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: PO BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482-2600 BUSINESS PHONE: 6106691000 MAIL ADDRESS: STREET 1: PO BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482-2600 SC 13G/A 1 tv0462-bostonscientificcorp.htm SCHEDULE 13G/A bostonscientificcorp SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer:  Boston Scientific Corp Title of Class of Securities:  Common Stock CUSIP Number:  101137107 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on the following page(s))     13G CUSIP No.:  101137107 1.  NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON The Vanguard Group - 23-1945930 2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP A.  B.  X 3.  SEC USE ONLY 4.  CITIZENSHIP OF PLACE OF ORGANIZATION Pennsylvania (For questions 5-8, report the number of shares beneficially owned by each reporting person with:) 5.  SOLE VOTING POWER 0 6.  SHARED VOTING POWER 1,826,242 7.  SOLE DISPOSITIVE POWER 119,279,981 8.  SHARED DISPOSITIVE POWER 6,169,614 9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 125,449,595 10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES N/A 11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.56% 12.  TYPE OF REPORTING PERSON IA     SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Act of 1934 Item 1(a) - Name of Issuer: Boston Scientific Corp Item 1(b) - Address of Issuer's Principal Executive Offices: 300 Boston Scientific Way Marlborough, MA 01752-1234 Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930 Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355 Item 2(c) – Citizenship: Pennsylvania Item 2(d) - Title of Class